MedTrace Logo

Pharmacokinetic Characteristics and Safety After Administration of NVP-2002

NCT04961905 · Status: COMPLETED · Phase: PHASE1 · Type: INTERVENTIONAL · Enrollment: 96

Last updated 2023-10-05

No results posted yet for this study

Summary

The purpose of this study is to compare and evaluate the pharmacokinetic characteristics and safety after administration of NVP-2002 and co-administration of NVP-2002-R1 and NVP-2002-R2 in healthy adult volunteers.

Conditions

  • Healthy

Interventions

DRUG

NVP-2002-R1+NVP-2002-R2

NVP-2002-R1 1 tablet, once daily and NVP-2002-R2 1 tablet, once daily

DRUG

NVP-2002

NVP-2002 is a combination of NVP-2002-R1 and NVP-2002\_R2 NVP-2002, 1 tablet, once daily

Sponsors & Collaborators

  • NVP Healthcare

    lead INDUSTRY

Principal Investigators

  • Min-Gul Kim, M.D., Ph.D · Jeonbuk National University Hospital

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
CROSSOVER

Eligibility

Min Age
19 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2022-09-03
Primary Completion
2023-04-25
Completion
2023-05-30

Countries

  • South Korea

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04961905 on ClinicalTrials.gov